4.8 Article

Structural basis for translational inhibition by the tumour suppressor Pdcd4

期刊

EMBO JOURNAL
卷 28, 期 3, 页码 274-285

出版社

WILEY
DOI: 10.1038/emboj.2008.278

关键词

Pdcd4; RNA helicase; translation initiation; translational control; tumour suppressor

资金

  1. Biomedical Research Council of A*STAR (Agency for Science, Technology and Research)
  2. University of Kentucky [P20 RR020171]
  3. National Center for Research Resources
  4. Medical Research Council [G0500367] Funding Source: researchfish
  5. MRC [G0500367] Funding Source: UKRI

向作者/读者索取更多资源

Pdcd4 is a tumour suppressor protein. It inhibits translation through interaction with translation initiator eIF4A, resulting in the suppression of neoplastic transformation and tumour invasion. Here, we present the crystal structures of an N-terminal- truncated Pdcd4 in free form and in complex with eIF4A. Upon binding to eIF4A, Pdcd4 undergoes a marked conformational change to form a hetero-trimeric complex with eIF4A, with one Pdcd4 binding to two eIF4A molecules in two different modes. The binding of Pdcd4 to eIF4A is required to inhibit the enzymatic activity of eIF4A, translation initiation, and AP-1-dependent transcription. Both MA3 domains are required to efficiently compete with the C-terminal domain of eIF4G (eIF4Gc) for binding to eIF4A whereas a single MA3 is sufficient to inhibit translation. Our structural and mutational analyses reveal that Pdcd4 inhibits translation initiation by trapping eIF4A in an inactive conformation, and blocking its incorporation into the eIF4F complex.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据